The capability of DNA vaccine to transfect cells determines the success of DNA vaccine, but there are some natural obstacles that reduce the efficiency of DNA delivery into cells. One way to overcome this problem is through the use of a delivery systems such as needle free injectors (NFIT). In the present study, we evaluated 2 kinds of NFITs, Injex and Twin-Jector EZII, and as control we use hypodermic syringes. The path of injection and the capability of NFITs to deliver DNA into cells were observed by using India ink and plasmid coding enhanced green fluorescent protein (pCDNA eGFP) respectively. A mass of 50 µg pcDNA3.1-eGFP in 50 µL of PBS and India ink were injected into the mouse thigh using these three delivery systems. Two days post-injection, histological slides were prepared from the thigh muscle and the expression of eGFP was observed by confocal microscopy. The results show that all the delivery systems used in the present study were able to deliver India ink and pcDNA3.1-eGFP to the thigh muscle. There was a difference in the spread of Indian ink produced 3 kinds of delivery systems used in this study. Furthermore, there was also a difference in the distribution of eGFP expression cells, that corelated with the pattern of the path /spread of fluid produced by the three delivery systems. The number and intensity cell expressing eGFP was intense in mice injecting with hypodermic syring compare to Injex and Twin-Jector EZII. - The results seen with India ink support the eGFP expression results. In conclusion, needle free injection can be used to deliver DNA into BALB/c muscle, but less efficient compared to hypodermic syringe.

1.
N.
Bruffaerts
,
K.
Huygen
and
M.
Romano
,
Expert Opin Biol Ther
14
(
12
),
1801
13
(
2014
).
2.
J.F.
Mann
,
P.F.
McKay
,
A.
Fiserova
,
K.
Klein
,
A.
Cope
,
P.
Rogers
,
J.
Swales
,
M.S.
Seaman
,
B.
Combadiere
and
R.J.
Shattock
,
J Virol
88
(
12
),
6959
69
(
2014
).
3.
B.
Yang
,
J.
Jeang
,
A.
Yang
,
T.C.
Wu
and
C.F.
Hung
,
Hum Vaccin Immunother
10
(
11
),
3153
64
(
2014
).
4.
L.Y.Y.
Lee
,
L.
Izzard
and
A.C.
Hurt
,
Front Immunol
9
,
1568
(
2018
).
5.
P.
Koraka
,
B.E.E.
Martina
and
A.D.M.E.
Osterhaus
,
J Biomed Biotechnol
2010
,
864029
(
2010
).
6.
F.
Saade
and
N.
Petrovsky
,
Expert Rev Vaccines
11
(
2
),
189
209
(
2012
).
7.
S.
Moreno
and
M.
Timón
,
Inmunología
,
23
(
1
),
41
55
(
2004
).
8.
A.
Stachyra
,
P.
Redkiewicz
,
P.
Kosson
,
A.
Protasiuk
,
A.
Gora-Sochaka
,
G.
Kudla
and
A.
Sirko
,
Virol J.
13
(
1
),
143
(
2016
).
9.
E.F.
Fedorova
,
I.V.
Kiseleva
,
P.
Auewarakul
,
O.
Suptawiwat
and
L.G.
Rudenko
,
Mol Gen Microbiol Virusol
(
4
),
3
9
(
2014
).
10.
Y.
Wang
,
Y.
Guo
,
X.
Wang
,
J.
Huang
,
J.
Shang
and
S.
Sun
,
J Immunol
186
(
5
),
2860
70
(
2011
).
11.
T.R.
Kale
and
M.
Momin
,
Innov Pharm
5
(
1
),
1
8
(
2014
).
12.
L.
Li
and
N.
Petrovsky
,
Expert Rev Vaccines
15
(
3
),
313
329
(
2016
).
13.
A.D.
Ravi
,
D.
Sadhna
,
D.
Nagpaal
and
L.
Chawla
,
Int J Pharm Investig
5
(
4
),
192
199
(
2015
).
14.
[
B.
Chavan
,
A.
Doshi
,
Y.
Malode
and
B
Misal
,
Int J Pharm Res. Rev
2
(
9
),
30
36
(
2013
).
15.
A.
Schoubben
,
A.
Cavicchi
,
L.
Barberini
,
A.
Faraon
,
M.
Berti
,
M.
Ricci
,
P.
Blasi
and
L.
Postrioti
,
Int J Pharm
491
(
1-2
),
91
98
(
2015
).
16.
S.L.
Patwekar
,
S.G.
Gattani
and
M.M.
Pande
,
Int J Pharm Pharm Sci
5
(
4
),
14
19
(
2013
).
17.
D.
Barolet
and
A.
Benohanian
,
Clin Cosmet Investig Dermatol
1
(
11
),
231
238
(
2018
).
18.
R.D.
Campbell
,
J Cell Sci
13
(
3
),
651
61
(
1973
).
19.
S.
Ren
,
M.
Li
,
J.M.
Smith
,
L.J.
DeTolla
and
P.A.
Furth
,
BMC Biotechnol
2
,
10
(
2002
).
20.
S.
Rao
,
W.P.
Kong
,
C.J.
Wei
,
Z.Y.
Yang
,
M.
Nason
,
D.
Styles
,
L.J.
DeTolla
,
E.M.
Sorrell
,
H.
Song
,
H.
Wan
,
G.C.
Ramirez-Nieto
,
D.
Perez
and
G.J.
Nabel
,
PloS One
3
(
6
),
e2432
(
2009
).
21.
D.B.
Lowrie
and
R.G.
Whalen
.
DNA Vaccine: Methods and Protocols
., (
Humana Press
,
1999
).
22.
B.P.
Cormack
,
R.H.
Valdivia
and
S.
Falkow
,
Gene
173
(
1 Spec No
),
33
8
(
1996
).
23.
N.C.
Shaner
,
G.H.
Patterson
and
M.W.
Davidson
,
J. Cell Sci.
120
(
Pt 24
),
4247
4260
(
2007
).
24.
J.
Wiedenmann
,
F.
Oswald
and
G.U.
Nienhaus
,
IUBMB Life
61
(
11
),
1029
42
(
2009
).
25.
T.W.
Kim
,
C.F.
Hung
,
M.
Ling
,
J.
Juang
,
L.
He
,
J.M.
Hardwick
,
S.
Kumar
and
T.C.
Wu
,
J Clin Invest.
112
(
1
),
109
117
(
2003
).
26.
J.
Du.
,
X.
Wu
,
F.
Long
,
J.
Wen
,
W.
Hao
,
R.
Chen
,
X.
Kong
,
M.
Qian
&
W.
Jiang
,
Viral Immunol
26
(
1
),
68
74
(
2013
).
27.
P.
Degano
,
D.F.
Sarphie
and
C.R.M.
Bangham
,
Vaccine
16
:
394
398
(
1998
).
28.
Y.
Omori-Urabe
,
K.
Yoshii
,
A.
Ikawa-Yoshida
,
H.
Kariwa
and
I.
Takashima
,
Microbiol Immunobiol
55
(
12
),
893
7
(
2011
).
29.
J.A.
Wolff
,
R.W.
Malone
,
P.
Williams
,
W.
Chong
W,
G.
Acsadi
,
A.
Jani
and
P.L.
Felger
,
Science
247
(
4949 Pt.1
),
1465
8
(
1990
).
30.
B.
Combadiere
and
C.
Liard
,
Hum Vaccin
7
(
8
),
811
27
(
2011
).
31.
J.A.
Wolff
and
V.
Budker
,
Adv Genet
54
,
3
20
(
2005
).
32.
A.
Fargas
,
J.
Roma
,
M.
Gratacȯs
and
M.
Roig
.,
Ann Anat
185
(
2
),
183
187
(
2003
).
33.
A.
Schoubben
,
A.
Cavicchi
,
L.
Barberini
,
A.
Faraon
,
M.
Berti
,
M.
Ricci
,
P.
Blasi
P and
L.
Postrioti
,
Int J Pharm
491
(
1-2
),
91
8
(
2015
).
34.
J.C.J.
Wei
,
G.A.
Edwards
,
D.J.
Martin
,
H.
Huang
,
M.L.
Crichton
and
M.A.F.
Kendal
,
Sci Rep
7
(
1
),
15885
(
2017
).
35.
S.
Mitragotri
.
Nat Rev Drug Discov
5
(
7
),
543
548
(
2006
).
36.
K.
Kelly
,
A.
Loskutov
,
D.
Zehrung
,
K.
Puaa
,
P.
LaBarre
,
N.
Muller
,
W.
Guiqiang
,
H.G.
Ding
,
D.
Hu
and
W.C.
Blackwelder
,
Vaccine
26
(
10
),
1344
1352
(
2008
).
This content is only available via PDF.